AzTrials
AzTrials

Joint InstabilityNCT02682654

A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability

A study testing Dr. Scholl's Prototype Ankle Brace and Dr. Scholl's Prototype Knee Brace in people with Joint Instability, run by Bayer at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will look to examine the overall performance of a custom fit knee or ankle brace as a means of providing ankle or knee joint support in subjects that have determined the need for bracing based upon chronic joint instability and/or joint swelling and pain following daily activity. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Joint Instability
What is being tested?
Dr. Scholl's Prototype Ankle Brace and Dr. Scholl's Prototype Knee Brace
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
183 participants
Where
2 sitesUnited States
Study dates
5 Feb 2016to 26 Apr 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects must indicate that they currently have weakened ankles or knees and that they experience chronic discomfort after performing daily activities.
  • Subjects must suffer from pain assessed on a 100 mm (10 cm) Visual Analog Scale (VAS) of ≥20 mm to ≤ 90 mm for subjects with either unstable ankle or unstable knee, at Visit 1 and 2.
  • Subjects must be able to walk unaided by cane or walker.
  • Subjects must not have a noticeable limp or other permanent ailment that interferes with normal gait.
  • Subjects free of other types of health problems that, in the opinion of the Investigator, could influence their ability to participate.
  • If subjects are taking pain medication (prescription or Over-the-counter (OTC)) for a chronic condition, they may continue that medication as long as they have been on a stable dose for at least 2 months, and agree to continue their regular dose and regimen for the duration of the study.
  • Subjects must be willing to undergo a 1-week period without a brace and then willing to wear a brace for a 1-week period, that is: 8 ±2 hours a day for a minimum of 5 out of 7 days.

Who cannot join

  • Subjects with an ankle or knee pain and instability which is due to a recent sprains, strains, or other non-reversible injury to the knee or ankle.
  • Subjects who have diabetes, circulatory problems, open wounds, and lack of sensation in the ankles, knees, or feet or any problems that would make brace wear uncomfortable or inappropriate.
  • Subjects who wear a physician-prescribed orthotic device, prescription shoes or back braces.
  • Subjects who are undergoing traction or manipulative back adjustments or have had a traumatic injury to the lower extremity (deemed of non-overuse nature), which in the opinion of the examining Investigator would interfere with the study evaluations.
  • Subjects whose condition requires surgery or other medical intervention or who have undergone foot back or knee surgery within the past 3 months or with any planned surgeries and/or invasive medical procedures during the course of the study.
  • Subjects who are currently taking an opioid based pain medication or have taken such medication within 2 months prior to Visit 1.
Show all 9Show fewer
  • Subjects who are taking any chronic pain medication (prescription or OTC) for at least 2 months, who do not agree to continue taking it at the same dose and regimen throughout the study.
  • Subjects who have severely painful bunions, warts, corns and/or calluses, severely overlapping toes or lesions on the bottom of their foot.
  • Subjects who have sensitivities or allergies to plastics or adhesives.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Study site

    Colorado Springs, Colorado, 80915

  • Study site

    Richardson, Texas, 75081

Other trials in United States

About this study

This study will look to examine the overall performance of a custom fit knee or ankle brace as a means of providing ankle or knee joint support in subjects that have determined the need for bracing based upon chronic joint instability and/or joint swelling and pain following daily activity.

Being tested
Dr. Scholl's Prototype Ankle Brace, Dr. Scholl's Prototype Knee Brace
Keywords
Pain, Ankle, Knee, Brace
Medical subject headings
Joint Instability, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dr. Scholl's Prototype Ankle BraceDevice

    Subjects will be instructed to wear the assigned Ankle/Knee brace for 8 ± 2 hours per day, for a minimun of 5 days out of a 7-day/1 week wear period.

  • Dr. Scholl's Prototype Knee BraceDevice

    Subjects will be instructed to wear the assigned Ankle/Knee brace for 8 ± 2 hours per day, for a minimun of 5 days out of a 7-day/1 week wear period.

Study groups in NCT02682654
Study groupRoleWhat they receive
Ankle/Knee braceExperimentalDr. Scholl's Prototype Ankle or Knee Brace
Receives: Device: Dr. Scholl's Prototype Ankle Brace; Device: Dr. Scholl's Prototype Knee Brace

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comfort

    Comfort is assessed utilizing a 7-point Comfort/Discomfort Likert scale.

    Measured: Up to 15 days

  2. Pain Relief of Knee or Ankle joint

    Evaluation of Knee or Ankle joint pain will be performed using the Visual Analog Scale utilizing a 100 mm line defined at each end of the line by 0 = no pain and 100 = Worst pain possible.

    Measured: Up to 15 days

Secondary outcomes (4)
  1. Product Fit

    Product Fit is assessed utilizing a 7-point scale.

    Measured: Up to 15 days

  2. Product Support

    Support is assessed utilizing a 5-point scale.

    Measured: Up to 15 days

  3. Freedom of Movement

    Freedom of Movement is assessed utilizing a 6-point scale.

    Measured: Up to 15 days

  4. Subjective Questions

    Applicable subjective questions will be assessed utilizing the subjective questionnaire.

    Measured: Up to 15 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2016 (estimated)
  2. Study start5 Feb 2016
  3. Primary completion26 Apr 2016
  4. Study completion26 Apr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
183 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02682654
Sponsor's protocol ID
18325
Status last verified
Dec 2018
First submitted
11 Feb 2016
Last updated
12 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Dr. Scholl's Prototype Ankle Brace and Dr. Scholl's Prototype Knee Brace in people with Joint Instability, run by Bayer at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comfort (time frame: Up to 15 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in